Frequency of three common mutations of CARD15/NOD2 gene in Iranian IBD patients.

BACKGROUND The CARD15/NOD2 gene, located on the pericentromeric region of chromosome 16 (IBD1) has been reported to have an association with IBD, especially Crohn's disease. Three common mutations of CARD15 are variably associated with Crohn's disease in different ethnic groups. We evaluated the frequency of these mutations (R702W, G908R and 1007fsinsC) in Iranian IBD patients and compared it with the healthy control population. METHODS One hundred patients with ulcerative colitis, 40 patients with Crohn's disease, and 100 sex- and age-matched controls were enrolled from a tertiary center during a one-year period (2005-2006). The three mutations were assessed in DNA of leukocytes by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP). RESULTS The frequency of R702W mutation was significantly higher in Iranian patients with Crohn's disease (p< 0.001; OR 19.21; 95% CI 4.23-87.32) compared to healthy controls. No association was observed between the other mutations and Crohn's disease and none of these mutations was associated with ulcerative colitis. CONCLUSION The R702W mutation of CARD15 gene was associated with Crohn's disease in the Iranian population.

[1]  M. Zali,et al.  The frequency of C3435T MDR1 gene polymorphism in Iranian patients with ulcerative colitis , 2007, International Journal of Colorectal Disease.

[2]  Mohammad Reza Zali,et al.  Inflammatory bowel disease in Iran: A review of 457 cases , 2005, Journal of gastroenterology and hepatology.

[3]  T. Molnár,et al.  Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations. , 2005, World journal of gastroenterology.

[4]  M. Gazouli,et al.  Association of NOD2/CARD15 variants with Crohn's disease in a Greek population , 2004, European journal of gastroenterology & hepatology.

[5]  Tomohiro Watanabe,et al.  NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses , 2004, Nature Immunology.

[6]  P. Lakatos,et al.  NOD2/CARD15 mutációk és a genotípus-fenotípus kapcsolatának multicentrikus vizsgálata Crohn-betegségben Magyarországon , 2004 .

[7]  J. Rioux,et al.  Genome scan analyses and positional cloning strategy in IBD: successes and limitations. , 2004, Best practice & research. Clinical gastroenterology.

[8]  T. Ahmad,et al.  Clinical relevance of advances in genetics and pharmacogenetics of IBD. , 2004, Gastroenterology.

[9]  J. Genschel,et al.  Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation , 2004, Alimentary pharmacology & therapeutics.

[10]  M. Daly,et al.  Inflammatory bowel disease susceptibility loci defined by genome scan meta-analysis of 1952 affected relative pairs. , 2004, Human molecular genetics.

[11]  G. Novelli,et al.  CARD15 Mutation Analysis in an Italian Population: Leu1007fsinsC but Neither Arg702Trp nor Gly908Arg Mutations Are Associated with Crohn’s Disease , 2004, Inflammatory bowel diseases.

[12]  Judy H. Cho,et al.  MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. , 2003, American journal of human genetics.

[13]  J. Hugot,et al.  Lessons from Nod2 studies: towards a link between Crohn's disease and bacterial sensing. , 2003, Trends in immunology.

[14]  J. Hugot,et al.  Card15 gene overexpression in mononuclear and epithelial cells of the inflamed Crohn’s disease colon , 2003, Gut.

[15]  D. Jewell,et al.  NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population , 2003, Alimentary pharmacology & therapeutics.

[16]  M. Färkkilä,et al.  CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn’s disease , 2003, Gut.

[17]  S. Targan,et al.  A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. , 2003, American journal of human genetics.

[18]  Judy H. Cho,et al.  The genetics of inflammatory bowel disease. , 2003, Gastroenterology.

[19]  Yusuke Nakamura,et al.  Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease , 2002, Journal of Human Genetics.

[20]  T. Hibi,et al.  Lack of common NOD2 variants in Japanese patients with Crohn's disease. , 2002, Gastroenterology.

[21]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[22]  Alastair Forbes,et al.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. , 2002, Gastroenterology.

[23]  C. O'Morain,et al.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. , 2002, American journal of human genetics.

[24]  B. Alizadeh,et al.  CARD15 gene and the classification of Crohn's disease , 2002, Immunogenetics.

[25]  G. Núñez,et al.  The NOD: a signaling module that regulates apoptosis and host defense against pathogens , 2001, Oncogene.

[26]  S. Fisher,et al.  Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations , 2001, The Lancet.

[27]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[28]  Judy H. Cho,et al.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease , 2001, Nature.

[29]  S. Yamaoka,et al.  Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB* , 2001, The Journal of Biological Chemistry.

[30]  Y. Ogura,et al.  Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides* , 2001, The Journal of Biological Chemistry.

[31]  J. Satsangi,et al.  Inflammatory bowel disease: progress toward a gene. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[32]  MariaGazouli,et al.  Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15／NOD2 and inflammatory bowel disease in the Greek population , 2005 .

[33]  T. Molnár,et al.  [NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study]. , 2004, Orvosi hetilap.

[34]  K. Huse,et al.  Haplotype structure and association to Crohn's disease of CARD15 mutations in two ethnically divergent populations , 2003, European Journal of Human Genetics.

[35]  Judy H. Cho,et al.  Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. , 2003, Gastroenterology.

[36]  Judy H. Cho,et al.  The genetics of inflammatory bowel disease. , 2003, Gastroenterology.

[37]  J. Colombel.  The CARD15 (also known as NOD2) gene in Crohn's disease: are there implications for current clinical practice? , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[38]  D. Podolsky,et al.  Inflammatory bowel disease. , 2002, The New England journal of medicine.

[39]  S. Targan,et al.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. , 2002, Gastroenterology.